{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T05:11:08Z","timestamp":1698383468660},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T00:00:00Z","timestamp":1151625600000},"content-version":"vor","delay-in-days":3712,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[1996,5]]},"abstract":"<jats:p>Ventricular arrhythmias remain a major problem, in particular in patients with left ventricular dysfunction or heart failure. In this group of patients, Class I drugs were shown to be ineffective, and they even increased mortality during chronic treatment. New antiarrhythmic agents should preferably not only have pure antiarrhythmic effects, but should also be free from adverse autonomic properties. In the present study, the electrophysiological, rate dependent and autonomic effects of intravenously administered almokalant, a new Class III antiarrhythmic drug, were investigated in nine pigs surviving a myocardial infarction. The ventricular effective refractory period (VERP) increased after almokalant (loading dose: 0.05 \u03bcmoLkg <jats:sup>\u22121<\/jats:sup> .min<jats:sup>\u22121<\/jats:sup>, continuous infusion: 0.0025 u\u03bcmol\/kg<jats:sup>\u22121<\/jats:sup>.min<jats:sup>\u22121<\/jats:sup>) from 292 \u00b1 25 to 308 \u00b1 13 ms (pacing cycle length [PCL] 500 ms + 1 extrasystole [ES]), from 249 \u00b1 19 to 261 \u00b1 16 ms (PCL 400 ms +1ES), and from 209 \u00b1 18 to 219 \u00b1 18ms (PCL 300 ms +1ES). The VERPs increased most after three ES at PCL 400 ms: from 167 \u00b1 27 to 186 \u00b1 29 ms (P &lt; 0.05) and at PCL 300 ms: from 159 \u00b1 29 to 174 \u00b1 27 ms (P &lt; 0.05). The ventricular monophasic action potential durations (MAPD) were similarly prolonged and the ratio VERP\/MAPD did not change. Prolongation of MAPD after almokalant remained present at short pacing cycle lengths. Before almokalant infusion, sustained monomorphic ventricular tachycardia (VT) was inducible in two pigs, and nonsustained VT in a third animal. After almokalant, only one pig remained inducible. Two weeks after myocardial infarction, heart rate variability and baroreflex sensitivity were reduced. Furthermore, subsequent electrophysiological testing transiently reduced these parameters of autonomic activity. During almokalant however, no changes in autonomic functions were observed after programmed stimulation. Heart rate variability decreased after myocardial infarction from 6.3 \u00b1 2.5 ms to 5.4 \u00b1 4,2 ms (P = NS}. After programmed stimulation, it further decreased to 2.8 \u00b1 2.0 ms (P = 0.028). Almokalant infusion prevented autonomic deterioration: 3.3 \u00b1 2.2 ms before stimulation and 3.3 \u00b1 1.3 after stimulation (P = NS). In postinfarct pigs, almokalant prolongs VERP and MAPD at shorter pacing cycle lengths. The results indicate absence of reverse rate dependence and of adverse autonomic changes.<\/jats:p>","DOI":"10.1111\/j.1540-8159.1996.tb03362.x","type":"journal-article","created":{"date-parts":[[2006,7,2]],"date-time":"2006-07-02T17:09:49Z","timestamp":1151860189000},"page":"802-810","source":"Crossref","is-referenced-by-count":2,"title":["Electrophysiological, Rate Dependent, and Autonomic Effects of the Class III Antiarrhythmic Almokalant After Myocardial Infarction in the Pig"],"prefix":"10.1111","volume":"19","author":[{"given":"YPE S.","family":"TUININGA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GEES D.J.","family":"De LANGEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HARRY J.G.M.","family":"CRIJNS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANS C.P.","family":"WIESFELD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PIET H.","family":"MOOK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KLAAS J.","family":"BEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KONG I.","family":"LIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,30]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.81.2.686"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1992.tb31011.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-3-370"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.60.2.117"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.67.6.482"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0033-0620(88)90014-X"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199112000-00015"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/27.5.861"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199209000-00018"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.73.5.857"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90349-4"},{"key":"e_1_2_1_13_2","first-page":"732","article-title":"The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs","volume":"19","author":"Tobe TJM","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199203000-00017"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.64.2.235"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1992.tb02964.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90795-8"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.65.1.14"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.66.4.874"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198601000-00026"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90191-M"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.79.4.948"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(92)90349-5"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(85)90233-9"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)91062-4"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(92)90270-6"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(10)80172-X"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/13.suppl_F.38"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198908103210629"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90027-A"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)91213-1"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(87)90258-4"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.69.4.790"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.78.4.816"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1987.tb11210.x"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.1996.tb03362.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.1996.tb03362.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T23:35:55Z","timestamp":1698363355000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.1996.tb03362.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["10.1111\/j.1540-8159.1996.tb03362.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.1996.tb03362.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}